Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
Completed
Shire
Phase 4
2005-01-10
The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis
level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and
to determine the patient and physician's satisfaction.
Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
Completed
Shire
Phase 2
2006-01-11
Chronic kidney disease (CKD) can result in a loss of ability to filter and excrete phosphate.
The body's attempt to adjust to an increased level of phosphate in the blood can result in
elevated levels of hormones and minerals resulting in serious clinical consequences. This
study is being conducted to evaluate the safety and efficacy of lanthanum carbonate in
lowering high levels of phosphorus in the blood in subjects with CKD Stages 3 and 4 compared
to placebo.
Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
Terminated
Shire
Phase 4
2007-05-22
The main aim of this research study is to see if giving Fosrenol®, a chewable tablet, to
patients on haemodialysis works as well as other treatments currently used to lower blood
phosphorus levels.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
